Structural typing of systemic amyloidoses by luminescent-conjugated polymer spectroscopy

American Journal of Pathology

Volumn 176, Issue 2, 2010, Pages 563-574

  Nilsson, K Peter R ^a,c   Ikenberg, Kristian ^b   Åslund, Andreas ^c   Fransson, Sophia ^a   Konradsson, Peter ^b   Röcken, Christoph ^d   Moch, Holger ^b   Aguzzi, Adriano ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c LINKÖPING UNIVERSITY   (Sweden)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; THIOPHENE;

ADOLESCENT; ADULT; AGED; AMYLOIDOSIS; ARTICLE; FLUORESCENCE MICROSCOPY; GEOMETRY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SPECTROSCOPY;

EID: 76149083590     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.080797     Document Type: Article

References (58)

1. Enqvist S, Sletten K, Stevens FJ, Hellman U, Westermark P: Germ line origin and somatic mutations determine the target tissues in systemic AL-amyloidosis. PLoS ONE 2007, 2:e981
2. Chiti F, Dobson CM: Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 2006, 75:333-366
3. Maji SK, Perrin MH, Sawaya MR, Jessberger S, Vadodaria K, Rissman RA, Singru PS, Nilsson KPR, Simon R, Schubert D, Eisenberg D, Rivier J, Sawchenko P, Vale W, Riek R: Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 2009, 325:328-332
4. Aguzzi A: Cell biology: Beyond the prion principle. Nature 2009, 459:924-925
5. Aguzzi A, Haass C: Games played by rogue proteins in prion disorders and Alzheimer's disease. Science 2003, 302:814-818
6. Aguzzi A, Polymenidou M: Mammalian prion biology: one century of evolving concepts. Cell 2004, 116:313-327
7. Dember LM: Emerging treatment approaches for systemic amyloidoses. Kidney Int 2005, 68:1377-1390
8. Comenzo RL: Current and emerging views and treatments of systemic immunoglobulin light-chain (AL) amyloidosis. Contrib Nephrol 2007, 153:195-210
9. Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, Masters CL, Merlini G, Saraiva MJ, Sipe JD: A primer of amyloid nomenclature. Amyloid 2007, 14:179-183
10. Obici L, Perfetti V, Palladini G, Moratti R, Merlini G: Clinical aspects of systemic amyloid diseases. Biochim Biophys Acta 2005, 1753:11-22
11. Sanchorawala V: Light-chain (AL) amyloidosis: diagnosis and treatment. Clin J Am Soc Nephrol 2006, 6:1331-1341
12. Sanchorawala V, Blanchard E, Seldin DC, O'Hara C, Skinner M, Wright DG: AL amyloidosis associated with B-cell lymphoproliferative disorders: frequency and treatment outcomes. Am J Hematol 2006, 81:692-695
13. Picken MM: New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens 2007, 16:196-203
14. Röcken C, Shakespeare A: Pathology, diagnosis and pathogenesis of AA amyloidosis. Virchows Arch 2002, 440:111-122
15. Lachmann HJ, Hawkins PN: Systemic amyloidosis. Curr Opinion Pharmacol 2006, 6:1-7
16. Pitkänen P, Westermark P, Cornwell GG: Senile systemic amyloidosis. Am J Path 1984, 117:391-399
17. Johansson B, Westermark P: Senile systemic amyloidosis: a clinicopathological study of twelve patients with massive amyloid infiltration. Int J Cardiol 1991, 32:83-92
18. Hawkins PN: Hereditary systemic amyloidoses with renal involvement. J Nephrol 2003, 16:443-448
19. Ando Y, Nakamura M, Araki S: Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005, 62:1057-1062
20. Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN: Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002, 346:1786-1791
21. Novak L, Cook WJ, Herrera GA, Sanders PW: AL-amyloidosis is underdiagnosed in renal biopsies. Nephrol Dial Transplant 2004, 19:3050-3053
22. Kebbel A, Röcken C: Immunohistochemical classification of amyloid in surgical pathology revisited. Am J Surg Pathol 2006, 30:673-683
23. Satoskar AA, Burdge K, Cowden DJ, Nadasdy GM, Hebert LA, Nadasdy T: Typing of amyloidosis in renal biopsies-diagnostic pitfalls. Arch Pathol Lab Med 2007, 131:917-922
24. Nilsson KPR, Herland A, Hammarström P, Inganäs O: Conjugated polyelectrolytes: conformation-sensitive optical probes for detection of amyloid fibril formation. Biochemistry 2005, 44:3718-3724
25. Herland A, Nilsson KPR, Olsson JDM, Hammarström P, Konradsson P, Inganäs O: Synthesis of a regioregular zwitterionic conjugated oligoelectrolyte, usable as an optical probe for detection of amyloid fibril formation at acidic pH. J Am Chem̈ Soc 2005, 127:2317-2323
26. Nilsson KPR, Hammarström P, Ahlgren F, Herland A, Schnell EA, Lindgren M, Westermark GT, Inganäs O: Conjugated polyelectrolytes- conformation-sensitive optical probes for staining and characterization of amyloid deposits. Chembiochem 2006, 7:1096-1104
27. Sigurdson CJ, Nilsson KPR, Hornemann S, Manco G, Polymenidou M, Schwarz P, Leclerc M, Hammarström P, Wuthrich K, Aguzzi A: Prion strain discrimination using luminescent conjugated polymers. Nat Methods 2007, 4:1023-1030
28. Nilsson KPR, Åslund A, Berg I, Nyström S, Konradsson P, Herland A, Inganäs O, Stabo-Eeg F, Lindgren M, Westermark GT, Lannfelt L, Nilsson LN, Hammarström P: Imaging distinct conformational states of amyloid-β fibrils in Alzheimer's disease using novel luminescent probes. ACS Chem Biol 2007, 2:553-560
29. Linke RP, Oos R, Wiegel NM, Nathrath WB: Classification of amyloidosis: misdiagnosing by way of incomplete immunohistochemistry and how to prevent it. Acta Histochem 2006, 108:197-208
30. Eriksson M, Buttner J, Todorov T, Yumlu S, Schonland S, Hegenbart U, Kristen AV, Dengler T, Lohse P, Helmke B, Schmidt H, Röcken C: Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid. Am J Surg Pathol 2009, 33:58-65
31. Åslund A, Herland A, Hammarström P, Nilsson KPR, Jonsson B-H, Konradsson P, Inganäs O: Studies of luminescent conjugated polythiophene derivatives: enhanced spectral discrimination of protein conformational states. Bioconjug Chem 2007, 18:1860-1868
32. Åslund A, Sigurdson CJ, Klingstedt T, Grathwohl S, Bolmont T, Dickstein DL, Glimsdal E, Prokop S, Lindgren M, Konradsson P, Holtzman DM, Hof PR, Heppner FL, Gandy S, Jucker M, Aguzzi A, Hammarström P, Nilsson KPR: Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem Biol 2009, 4:673-684
33. Ding LJM, Roman LS, Andersson MR, Inganäs O: Photovoltaic cells with a conjugated polyelectrolyte. Synt Met 2000, 110:133-140
34. Bubendorf L, Nocito A, Moch H, Sauter G: Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 2001, 195:72-79
35. Andersson MR, Berggren M, Olinga T, Hjertberg T, Inganäs O, Wennerstro ̈m O: Improved photoluminescence efficiency of films from conjugated polymers. Synthetic Metals 1997, 85:1383-1384
36. Berggren M, Bergman P, Fagerstrom J, Inganäs O, Andersson M, Weman H, Granström M, Stafström S, Wennerström O, Hjertberg T: Controlling inter-chain and intra-chain excitations of a poly(thiophene) derivative in thin films. Chem Phys Lett 1999, 304: 84-90
37. Nilsson KPR, Andersson MR, Inganäs O: Conformational transitions of a free amino-acid-functionalized polythiophene induced by different buffer systems. J Phys Condens Matter 2002, 14:10011-10020
38. Klein MA, Kaeser PS, Schwarz P, Weyd H, Xenarios I, Zinkernagel RM, Carroll MC, Verbeek JS, Botto M, Walport MJ, Molina H, Kalinke U, Acha-Orbea H, Aguzzi A: Complement facilitates early prion pathogenesis. Nat Med 2001, 7:488-492
39. Harper JD, Lansbury PT, Jr.: Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem 1997, 66:385-407
40. Harper JD, Wong SS, Lieber CM, Lansbury PT: Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem. Biol 1997, 4 119-125
41. Westermark GT, Johnson KH, Westermark P: Staining methods for identification of amyloid in tissue. Methods Enzymol 1999, 309:3-25
42. Aguzzi A: Unraveling prion strains with cell biology and organic chemistry, Proc Natl Acad Sci USA 2008, 105:11-12
43. Aguzzi A, Sigurdson C, Heikenwalder M: Molecular mechanisms of prion pathogenesis. Annu Rev Pathol 2008, 3:11-40
44. Sipe JD, Cohen AS: History of the amyloid fibril. J Struct Biol 2000, 130:88-98
45. Bellotti V, Mangione P, Merlini G: Immunoglobulin light chain amyloidosis - the archetype of structural and pathogenic variability. J Struct Biol 2000, 130:280-289
46. Furukawa Y, Kaneko K, Matsumoto G, Kurosawa M, Nukina N: Cross-seeding fibrillation of Q/N-rich proteins offers new pathomechanism of polyglutamine diseases. J Neurosci 2009, 29:5153-5162
47. Yan J, Fu X, Ge F, Zhang B, Yao J, Zhang H, Qian J, Tomozawa H, Naiki H, Sawashita J, Mori M, Higuchi K: Cross-seeding and cross-competition in mouse apolipoprotein A-II amyloid fibrils and protein A amyloid fibrils. Am J Pathol 2007, 171:172-180
48. Aguzzi A: Staining, straining and restraining prions. Nat Neurosci 2008, 11:1239-1240
49. Röcken C, Menard R, Buhling F, Vockler S, Raynes J, Stix B, Kruger S, Roessner A, Kahne T: Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation. Ann Rheum Dis 2005, 64:808-815
50. Enqvist S, Mellqvist UH, Molne J, Sletten K, Murphy C, Solomon A, Stevens FJ, Westermark P: A father and his son with systemic AL amyloidosis. Haematologica 2009, 94:437-439
51. Westermark P, Lundmark K, Westermark GT: Fibrils from designed non-amyloid-related synthetic peptides induce AA-amyloidosis during inflammation in an animal model. PLoS ONE 2009, 4:e6041
52. Kane MD, Lipinski WJ, Callahan MJ, Bian F, Durham RA, Schwarz RD, Roher AE, Walker LC: Evidence for seeding of β-amyloid by intracerebral infusion of Alzheimer brain extracts in β-amyloid precursor protein-transgenic mice. J Neurosci 2000, 20:3606-3611
53. Meyer-Luehmann M, Coomaraswamy J, Bolmont T, Kaeser S, Schaefer C, Kilger E, Neuenschwander A, Abramowski D, Frey P, Jaton AL, Vigouret JM, Paganetti P, Walsh DM, Mathews PM, Ghiso J, Staufenbiel M, Walker LC, Jucker M: Exogenous induction of cerebral β-amyloidogenesis is governed by agent and host. Science 2006, 313:1781-1784
54. Ren PH, Lauckner JE, Kachirskaia I, Heuser JE, Melki R, Kopito RR: Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol 2009, 11:219-225
55. Clavaguera F, Bolmont T, Crowther RA, Abramowski D, Frank S, Probst A, Fraser G, Stalder AK, Beibel M, Staufenbiel M, Jucker M, Goedert M, Tolnay M: Transmission and spreading of tauopathy in transgenic mouse brain. Nat Cell Biol 2009, 11:909-913:
56. Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, Lashley T, Quinn NP, Rehncrona S, Bjorklund A, Widner H, Revesz T, Lindvall O, Brundin P: Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat Med 2008, 14:501-503
57. Lundmark K, Westermark GT, Olsen A, Westermark P: Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: cross-seeding as a disease mechanism. Proc Natl Acad Sci USA 2005, 102:6098-6102
58. Röcken C, Sletten K: Amyloid in surgical pathology. Virchows Arch 2003, 443:3-16